1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow CELLECTRA® 2000: new trials by email Literature Review of CELLECTRA® 2000 trials Research Report on CELLECTRA® 2000
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure INO-4800, CELLECTRA® 2000, Placebo - Coronavirus Infection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Phase 2 / Phase 3 | Terminated | Inovio Pharmaceuticals | 1307 | 2020-11-30 | 2023-12-20 |
COVID-19 (1) · Coronavirus Infections (1)
Colombia (1) · Mexico (1) · United States (1)
Jose Suaya (1)